Patients continue to file Xarelto lawsuits against the drug’s manufacturers Janssen Pharmaceuticals and Bayer AG. Most recently, Jermaine McMillan accused the manufacturers in a West Virginia court of withholding Xarelto safety information from patients, doctors and the U.S. Food and Drug Administration (FDA).
McMillan reportedly suffered severe Xarelto side effects after being given the drug, including life-threatening bleeding. Thousands of other Xarelto patients have also raised alarming claims of side effects, including internal hemorrhaging, blood clots, strokes, heart attacks and other complications.
Xarelto was approved to treat patients who are at an increased risk of blood clots after suffering heart complications or some surgeries. The FDA denied Janssen and Bayer’s request to expand use of the drug on account of incomplete medical data, and some studies suggest a strong link between Xarelto and potentially life-threatening side effects.